AB0561 Risk of HBV infection reactivation in patients with rheumatoid arthritis undergoing treatment with ANTI-CD20 (RITUXIMAB)
Covelli, M., Lanciano, E., Notarnicola, A., Coladonato, L., Lopalco, G., Scioscia, C., Anelli, M.G., Lapadula, G.Volume:
71
Language:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2012-eular.561
Date:
June, 2013
File:
PDF, 63 KB
english, 2013